Relenza® News 

Biota settles Relenza legal action
Found on 26 Jul 2008 11:01 GMT

Biota Holdings has resolved legal action it took against global pharmaceutical group GlaxoSmithKline related to its perceived lack of support for Biota's Relenza flu treatment, after the pair were ordered into ...

Relenza, flovent HFA inhalation aerosol.(New & Approved)
Relenza (zanamivir for inhalation, GlaxoSmithKline) The Food and Drug Administration approved a new indication for Relenza (zanamivir for inhalation) for prevention of influenza in adults and children aged 5 years and older. * Recommended Dosage: Dosage is 10 mg (two inhalations) once a day for 10

Publication: Pediatric News

BIOTA ANNOUNCES TGA MARKETING CLEARANCE FOR RELENZA(R)
AAP General News (Australia) 03-27-1999 BIOTA ANNOUNCES TGA MARKETING CLEARANCE FOR RELENZA(R) BIOTA ANNOUNCES TGA MARKETING CLEARANCE FOR RELENZA(R) Melbourne, Australia, 26 March 1999/MediaNet International-AsiaNetBiota Holdings Limited announces that Glaxo Wellcome Australia has received

Publication: AAP General News (Australia)

Glaxo Wellcome Receives FDA Approval of Relenza: A New Medicine to Treat Infl...
Relenza(R) (Zanamivir for Inhalation) Reduces the Duration of Flu RESEARCH TRIANGLE PARK, N.C., July 27 /PRNewswire/ - The approval of the first in a new class of medicines may mean influenza patients will be back on their feet sooner this winter. Glaxo Wellcome announced today that the U.S. Food

Publication: PR Newswire

Biota blames GSK for Relenza failure.
Jul 27, 2005 (Herald Sun - ABIX via COMTEX) - In the Supreme Court of Victoria, biotechnology group Biota is suing the global GlaxoSmithKline (GSK) group. The Australian biotech believes that its legal case is strong. In its suit Biota alleges that GSK, which holds the development and

Publication: Australasian Business Intelligence

Relenza Saves You a Day.(Brief Article)
Each year, 25 to 50 million Americans suffer through the flu. Rather than reach for pills, sprays, and fluids, flu-carriers can now opt for an inhalant remedy. After some reluctance earlier this year, Relenza (Glaxo Wellcome Inc.) was finally approved by the Food and Drug Administration (FDA). In

Publication: Journal of Dental Hygiene

Glaxo celebrates as Relenza gets a booster from bird flu Glaxo celebrates as ...
Byline: TOM NICHOLLS GLAXOSMITHKLINE advanced 4p to 1317p after sales prospects for its antiviral Relenza drug were boosted by a report in the Lancet. The medical journal said the UK pharmaceutical giant's product may prove as effective as Roche Holding's Tamiflu drug in treating bird flu and that

Publication: The Evening Standard (London, England)

The Relenza War
Following is the full text of a letter from Tom McKillop, chairman of the British Pharma Group, to Britain's prime minister, Tony Blair. The letter responds to the National Institute of Clinical Excellence's (NICE) evaluation of Relenza, Glaxo Wellcome's new flu therapy. (See World News &

Publication: Pharmaceutical Executive

Canadian Government Orders 5.5M Courses of Relenza.
MELBOURNE, Australia, Nov. 13 /PRNewswire/ - Biota Holdings has been informed that the Canadian Government will increase the overall stockpile of antivirals to 55 million courses, and increase the proportion of Relenza(R) (zanamivir) to 5.5 million courses. The purchase follows the May 2006

Publication: PR Newswire

GLAXO INTRODUCES VILLAIN IN RELENZA ADS: NEWMAN `SEINFELD' CO-STAR RETURNS, T...
Jerry Seinfeld's nemesis takes on the role of a menacing contagion in an ad campaign for Glaxo Wellcome's Relenza. Wayne Knight, better known as the noisome Newman on ``Seinfeld premieres as ``the flu'' in ads for the new flu-fighting Relenza inhalant. Teaser ads broke last week; a full-scale

Publication: Advertising Age

UK GOVERNMENT: Dobson gives go ahead to NICE advice on on Relenza.
M2 PRESSWIRE-11 October 1999-UK GOVERNMENT: Dobson gives go ahead to NICE advice on Relenza (C)1994-99 M2 COMMUNICATIONS LTD RDATE:111099 The Secretary of State for Health Frank Dobson has asked the National Institute for Clinical Excellence (NICE) to issue guidance to the NHS on the influenza drug

Publication: M2 Presswire